Neuronavigation Systems Market Size, Share and Global Trend by Product (Optical Systems, Electromagnetic Systems), By Application (Neurosurgery, ENT Surgery, Maxillofacial Surgery, Spinal Surgery), By End Users (Hospitals, Ambulatory Surgery Centers), and Geography Forecast till 2022-2029

Neuronavigation refers to the set of computer-assisted technologies used by neurosurgeons for the guiding or navigation within the confines of the skull or vertebral column during surgery and transcranial magnetic stimulation. Neuronavigation systems have become a standard procedure for neurosurgery and associated specialties due to improved accuracy, safety and efficiency. Neuronavigation systems are extensively used in the operative management of brain tumors and offering numerous clinical advantages to the surgeon.

Certain other functionalities of the neuronavigation systems include precise planning of the incision & craniotomy and determination of small subcortical lesions. According to the American Society of Clinical Oncology (ASCO), in 2017, an approximate of 23,880 individuals (13,720 males and 10,160 females) in the U.S. were diagnosed with primary cancerous tumors of the brain and spinal cord. In 2013, two key neuronavigation systems market players Brainlab and DePuy Synthes launched navigation-ready instrumentation for neurology procedures.

To gain extensive insights into the market,Request for Customization

One of the key neuronavigation systems market growth drivers of the global neuronavigation systems is the growing incidence of neurological disorders such as cancer, benign tumors, and stroke. Introduction of new and innovative neuronavigation systems by market players is also fueling the demand and adoption of these systems in the global market.

However, clinical complications related to neuronavigation systems, combined with the high cost of acquisition and maintenance of these systems, are some of the major factors restraining the growth of the global neuronavigation systems in 2018.

Key Players Covered

Some of the major companies that are present in the neuronavigation systems market are Northern Digital Inc., ClaroNav, Medtronic, Stryker, BrainLAB AG, Synaptive Medical, and Parsis Co. and other players.

SEGMENTATION

SEGMENTATION	DETAILS
By Product	· Optical Systems · Electromagnetic Systems
By Application	· Neurosurgery · ENT Surgery · Maxillofacial Surgery · Spinal Surgery
By End Users	· Hospitals, · Ambulatory Surgery Centers · Others
By Geography	· North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Among products, the optical systems account for the largest proportion of the market. Electromagnetic systems are the most innovative neuronavigation systems and are quickly gaining on the market share of the product segment.

Key Insights

• Prevalence of Neurological Disorders, 2018 (Key Countries/ Region)


• Overview of Technological Advancements


• Overview of New Product Introductions


• Key Mergers and Acquisitions


• Overview of Opportunity Assessment of Neuronavigation Systems in Emerging Markets

Regional Analysis

The neuronavigation systems market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the highest share of the neuronavigation systems market share in 2018, due to the high prevalence of neurological disorders and the demand for technologically advanced neurological systems. In the Asia Pacific region, Japan is expected to provide the largest market opportunity. This is due to the high prevalence of the neurological diseases in the country and also, due to the developed healthcare infrastructure of the country.

Key Industry Developments

• In 2018, the Brightwater Guide system was recalled due to a potential risk where the malfunctioning software could damage the brain and cause life-threatening injuries.


• In April 2015, Synaptic Medical won the FDA clearance for its groundbreaking neuronavigation called Brightwater Guide system for the U.S.


• In October 2013, Brainlab and DePuy Synthes Spine launched navigation-ready instrumentation, in order to improve the patient outcomes and greater decision making during the surgery itself.